CD86 and myasthenia gravis: The idea that thymic microenvironment in MG patients is favourable to abnormal migration of T cells is further supported by the observation that the expression of CD152 (CTLA-4) and its CD86 ligand was increased in MG thymuses compared to controls (Table 2).